This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Consolidated Sep 2026 quarter revenue Rs 1,810 cr, up 36%; PAT Rs 120 cr, up 80%
GALAXYSURF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated quarter ended 30 Sep 2026: revenue Rs 1,810.41 cr, up 36.5% from Rs 1,326.17 cr a year earlier; PAT Rs 119.75 cr vs Rs 66.49 cr, up 80%; EBITDA margin widened about 2 points. Standalone quarter: revenue Rs 1,233.24 cr, up 34%; PAT Rs 66.47 cr, up 44%. Half-year consolidated PAT Rs 285.67 cr. Rs 18 interim dividend declared; new auditor and company secretary approved.
Strong year-on-year growth and higher margins plus Rs 18 interim dividend are positive; quarterly profit was below the June quarter.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹1,810 Cr | ₹1,326 Cr | +36.5% |
| Operating profit | ₹144.9 Cr | ₹73.41 Cr | +97.3% |
| Profit after tax | ₹119.8 Cr | ₹66.49 Cr | +80.1% |
| EBITDA margin | 10.5% | 8.3% | +2.1 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.